Literature DB >> 22642653

Enucleation and evisceration: 20 years of experience.

Salman J Yousuf1, Leslie S Jones, Earl D Kidwell.   

Abstract

OBJECTIVE: To determine the indications, relative frequencies, surgical times, and complications for enucleation and evisceration performed at a single academic center.
METHODS: Medical records of all patients who underwent an enucleation or evisceration between January 1st, 1990 and December 31st, 2009 at a single academic center were reviewed. Patient demographics and surgical indications, times, and complications were recorded.
RESULTS: A total of 85 eyes in 85 patients underwent enucleation (n = 31; 36%) or evisceration (n = 54; 64%) during the study period. Almost all patients were of African descent (96%). The most common underlying cause leading to eye removal was trauma. On average, eviscerations (47.3 ± 10.3 minutes) took significantly less time to perform than enucleations (89.6 ± 10.1 minutes; p < 0.01). Complications included implant exposure, infection, lower lid laxity, fornix insufficiency, and need for subsequent surgery; the occurrence of these complications was found to be similar between the two groups (p = 0.77). No case of sympathetic ophthalmia or inadvertent evisceration of an eye with an occult intraocular malignancy was noted. From the first decade for which data were available (1990- 1999) to the second decade (2000- 2009), the average number of enucleations decreased (p = 0.02) and the average number of eviscerations (p = 0.04) increased.
CONCLUSION: Evisceration was found to be a safe and quicker alternative to enucleation in our study. A change in surgical preference from enucleation to evisceration was seen during the 20-year study period.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22642653     DOI: 10.3109/01676830.2011.639477

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  11 in total

1.  Four petals evisceration for atrophia bulbi.

Authors:  Molham A Elbakary
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun

2.  Outcomes of ocular evisceration and enucleation in the British Armed Forces from Iraq and Afghanistan.

Authors:  Christopher J Holmes; Anthony McLaughlin; Tahir Farooq; John Awad; Aidan Murray; Robert Scott
Journal:  Eye (Lond)       Date:  2019-06-05       Impact factor: 3.775

3.  Autologous sclera-muscle flaps technique in evisceration with hydroxyapatite implantation.

Authors:  Ying Zhu; Hong Zhang; Yin-Wei Song; Jing-Min Guo; Xiao-Lan Xu; Jun-Ming Wang
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

4.  Removal of the eye in a tertiary care center of China: a retrospective study on 573 cases in 20 years.

Authors:  Ying Zhang; Mao-Nian Zhang; Xin Wang; Xiao-Fei Chen
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

5.  Common Causes of Eye Enucleation among Patients.

Authors:  A Farokhfar; A Ahmadzadeh-Amiri; M R Sheikhrezaee; Mohammad Ali Heidari Gorji; N Agaei
Journal:  J Nat Sci Biol Med       Date:  2017 Jul-Dec

6.  Enucleation and evisceration at a tertiary care hospital in a developing country.

Authors:  Osama H Ababneh; Eman A AboTaleb; Mohammad A Abu Ameerh; Yacoub A Yousef
Journal:  BMC Ophthalmol       Date:  2015-09-11       Impact factor: 2.209

7.  Indications for surgical removal of the eye in rural areas in cameroon.

Authors:  Giles Kagmeni; Christelle Domngang Noche; Georges Nguefack-Tsague; Peter Wiedemann
Journal:  Ophthalmol Eye Dis       Date:  2014-06-09

8.  Indications for eye removal surgeries. A 15-year experience at a tertiary military hospital.

Authors:  Mehmet T Koylu; Gokcen Gokce; Yusuf Uysal; Osman M Ceylan; Dorukcan Akıncıoglu; Armagan Gunal
Journal:  Saudi Med J       Date:  2015-10       Impact factor: 1.484

9.  Psychological symptoms in anophthalmic patients wearing ocular prosthesis and related factors.

Authors:  Kai Jie Wang; Sha Sha Li; Hai Yan Wang
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

10.  Indications for enucleation and evisceration in a tertiary eye hospital in Riyadh over a 10-year period.

Authors:  Saad A Al-Dahmash; Sawsan Saad Bakry; Nada H Almadhi; Lolwah M Alashgar
Journal:  Ann Saudi Med       Date:  2017 Jul-Aug       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.